Evidence map›Paper›PMID 41103012›Full record

ArticleCancer communications (London, England)2025

RNA m

Xiaoting Zhang, Na Qin, Fenfen Ji, Hao Su, Haiyun Shang, Hongyan Chen, Dan Huang, Qing Li, Jing Ren, Weixin Liu and 9 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer communications (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. mPharmaceuticals (Basel, Switzerland) · 2026
    Review
  3. Review
  4. RNA mCancer communications (London, England) · 2025
    Article
  5. Theranostics in nuclear medicine: the era of precision oncology.Medical oncology (Northwood, London, England) · 2025
    Review
  6. A primer on tRNAs, tRNA-mFrontiers in cell and developmental biology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Xiaoting ZhangDepartment of Anaesthesia and Intensive Care and Peter Hung Pain Research Institute, The Chinese University of Hong Kong, Hong Kong, P. R. China.
Na QinDepartment of Anaesthesia and Intensive Care and Peter Hung Pain Research Institute, The Chinese University of Hong Kong, Hong Kong, P. R. China.
Fenfen JiInstitute of Digestive Disease and Department of Medicine and Therapeutics, State Key Laboratory of Digestive Disease, Li Ka Shing Institute of Health Sciences, CUHK Shenzhen Research Institute, The Chinese University of Hong Kong, Hong Kong, P. R. China.
Hao SuDepartment of Anaesthesia and Intensive Care and Peter Hung Pain Research Institute, The Chinese University of Hong Kong, Hong Kong, P. R. China.
Haiyun ShangDepartment of Anaesthesia and Intensive Care and Peter Hung Pain Research Institute, The Chinese University of Hong Kong, Hong Kong, P. R. China.
Hongyan ChenDepartment of Anaesthesia and Intensive Care and Peter Hung Pain Research Institute, The Chinese University of Hong Kong, Hong Kong, P. R. China.
Dan HuangDepartment of Anaesthesia and Intensive Care and Peter Hung Pain Research Institute, The Chinese University of Hong Kong, Hong Kong, P. R. China.
Qing LiDepartment of Anaesthesia and Intensive Care and Peter Hung Pain Research Institute, The Chinese University of Hong Kong, Hong Kong, P. R. China.
Jing RenDepartment of Anaesthesia and Intensive Care and Peter Hung Pain Research Institute, The Chinese University of Hong Kong, Hong Kong, P. R. China.
Weixin LiuInstitute of Digestive Disease and Department of Medicine and Therapeutics, State Key Laboratory of Digestive Disease, Li Ka Shing Institute of Health Sciences, CUHK Shenzhen Research Institute, The Chinese University of Hong Kong, Hong Kong, P. R. China.
Yifei WangDepartment of Anatomical and Cellular Pathology, State Key Laboratory of Oncology in South China, The Chinese University of Hong Kong, Hong Kong, P. R. China.
Wei KangDepartment of Anatomical and Cellular Pathology, State Key Laboratory of Oncology in South China, The Chinese University of Hong Kong, Hong Kong, P. R. China.
Jiabin WuState Key Laboratory of Environmental and Biological Analysis, Hong Kong Baptist University, Hong Kong, P. R. China.
Chi-Chun WongInstitute of Digestive Disease and Department of Medicine and Therapeutics, State Key Laboratory of Digestive Disease, Li Ka Shing Institute of Health Sciences, CUHK Shenzhen Research Institute, The Chinese University of Hong Kong, Hong Kong, P. R. China.
Zongwei CaiState Key Laboratory of Environmental and Biological Analysis, Hong Kong Baptist University, Hong Kong, P. R. China.
Matthew Tak Vai ChanDepartment of Anaesthesia and Intensive Care and Peter Hung Pain Research Institute, The Chinese University of Hong Kong, Hong Kong, P. R. China.
William Ka Kei WuDepartment of Anaesthesia and Intensive Care and Peter Hung Pain Research Institute, The Chinese University of Hong Kong, Hong Kong, P. R. China.ORCID 0000-0002-4651-677X
Jun YuInstitute of Digestive Disease and Department of Medicine and Therapeutics, State Key Laboratory of Digestive Disease, Li Ka Shing Institute of Health Sciences, CUHK Shenzhen Research Institute, The Chinese University of Hong Kong, Hong Kong, P. R. China.ORCID 0000-0001-5008-2153
Huarong ChenDepartment of Anaesthesia and Intensive Care and Peter Hung Pain Research Institute, The Chinese University of Hong Kong, Hong Kong, P. R. China.ORCID 0000-0003-2192-1864

Funding

CUHK Direct Grant for Research 2024.010Heath and Medical Research Fund 22210032National Natural Science Foundation of China 82103245National Natural Science Foundation of China 82272989RGC-CRF Hong Kong C4008-23WRGC-CRF Hong Kong C4039-19GFRGC-CRF Hong Kong C4042-24GFRGC-GRF Hong Kong 14101922RGC-GRF Hong Kong 14104924RGC-GRF Hong Kong 14107321RGC-GRF Hong Kong 14111621
6 · The paper itself

Abstract

backgroundThe role of N1-methyladenosine (m

methodsRNA m

resultsOur research revealed a consistent increase in TRMT61A expression and total RNA m

conclusionsOur study unveiled the tumor-promoting role of TRMT61A in CRC via the m

Indexed as

Colorectal NeoplasmsRNA StabilitytRNA MethyltransferasesAdenosineAnimalsCarcinogenesisCell Line, TumorGene Expression Regulation, NeoplasticHumansMiceXenograft Model Antitumor AssaysAdenosinetRNA MethyltransferasesColorectal CancerMAPK/ERKN1‐MethyladenosineTherapeutic targetTRMT61A

Identifiers

PMID41103012
PMCPMC12728496

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.